glp-1 drugs kidney disease SGLT2 vs for CKD: Which Is Better? Renal effects of GLP-1 receptor

Rizzo M, Nikolic D, Patti AM, et al

In addition to regulating blood sugar and lowering body weight in non-diabetic obese patients, tirzepatide can also lower liver fat and improve kidney outcomes (Rosenstock et al., 2025)

doi: 10.1007/BF02581349 86 GiuglianoDPassarielloNSgambatoSTorellaRDOnofrioF

Reddy's Laboratories, becoming the first G7 country to approve a generic version of the molecule [Source: canada.ca/en/health-canada/news/2026/04/canada-becomes-the-first-g7-country-to-approve-a-generic-version-of-semaglutide.html]

38719), which would, if finalized, affect 503B bulk compounding of semaglutide and tirzepatide specifically - though the proposal itself isn't proof of which framework Zevay's named pharmacies actually use